Patients with a common heart rhythm disorder who took an experimental blood-thinning drug had far fewer bleeding episodes ...

"To promote the science and art of medicine and the betterment of public health." The A.M.A. has pursued its twin goals vigorously over these many years and has demonstrated a distinct and ...

About 29 million Americans struggle with alcohol use disorder. Earlier this month, the surgeon general released a new report ...

New approval brings the medicine to an earlier treatment setting and a broader patient population.

A new study highlights that the experimental blood-thinner abelacimab significantly reduces bleeding risks in atrial fibrillation patients compared to standard treatments like rivaroxaban. In trial ...

Many physicians are now using algorithms that consider a patient's sex, like heart disease risk assessment tools, to help ...

MedStar Washington Hospital Center has seen fewer babies with low birth weight after expanding its care model to focus on social needs, a study finds.

In 2024, Rwanda’s rapid detection of its MVD outbreak, incorporation of genomic analysis to inform contact tracing, rollout of trials to evaluate new tools, emphasis on universal access to high ...

A new treatment for sexually-transmitted diseases seems to be slowing an STI epidemic — but not everyone can get it ...